Meeting the Needs of Under-Represented Patients with IBD: Screening and Immunizations
Premiere Date: Tuesday, November 2, 2021This activity offers CE credit for:
- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, November 2, 2022
Note: Credit Is No Longer Available
 | Miguel Regueiro, MD, AGAF, FACG, FACP (Moderator) Chair, Digestive Disease and Surgery Chair, Department of Gastroenterology, Hepatology, and Nutrition The Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology Professor, Department of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, OH |
 | Patricia Ajayi-Fox, MD Associate Staff Department of Gastroenterology, Hepatology, and Nutrition Cleveland Clinic Foundation Cleveland, OH |
 | Sophie Balzora, MD, FACG (she/her/hers) Clinical Associate Professor of Medicine NYU Grossman School of Medicine Division of Gastroenterology and Hepatology NYU Langone Health New York, NY |
Preventive care, including immunizations, is imperative for proper disease management and health care maintenance in patients with inflammatory bowel disease (IBD). Unfortunately, the newest treatment approaches are not equally applied to all populations with IBD, with minorities often experiencing suboptimal management of the disease.
In this CME Outfitters Live and OnDemand, expert faculty will address the disparities in preventive care for patients with IBD and unique approaches to managing underserved patients, including integrating recommended immunizations and preventive screenings so that all patients with IBD receive quality, well-rounded care.
At the end of this CE activity, participants should be able to:
- Integrate recommended immunizations and preventive screenings into practice to improve health outcomes in all patients with IBD.
- Implement strategies to address disparities in care in patients with IBD by establishing trust, providing education, and engaging in shared decision-making (SDM).
Supported by educational grants from AbbVie Inc.; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc.
Gastroenterologists, PAs, nurse practitioners, nurses, dietitians, and pharmacists
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring material
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Regueiro receives research support from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He receives unrestricted educational grants from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Salix Pharmaceuticals; Shire; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc. He is on advisory boards and consults for AbbVie Inc.; Amgen Inc.; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Miraca Laboratories; Pfizer Inc.; Seres Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.
Dr. Ajayi-Fox has no disclosures to report.
Dr. Balzora reports she is a consultant for Pfizer, Inc.
S. Michelle Franks, MSN, APRN, FNP-BC (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Susan Perry (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-131-110221-90
